A human hepatocellular in vitro model to investigate steatosis.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Chemico-Biological Interactions

• Publication date

  2007-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CBI.2006.11.004PMID 17188672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.

  2006cited by this paper
• Apoptosis and necrosis in the liver: A tale of two deaths?

  2006cited by this paper
• Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis*

  2006cited by this paper
• Potential Impact of Steatosis on Cytochrome P450 Enzymes of Human Hepatocytes Isolated from Fatty Liver Grafts

  2006cited by this paper
• Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells.

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis.

  2006cited by this paper
• Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes.

  2005cited by this paper
• Steatosis: Co‐factor in other liver diseases

  2005cited by this paper
• Nonalcoholic fatty liver disease: defining a common problem.

  2005cited by this paper
• Saturated free fatty acid, palmitic acid, induces apoptosis in fetal hepatocytes in culture.

  2005cited by this paper
• Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.

  2005cited by this paper
• Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.

  2004cited by this paper
• Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.

  2004cited by this paper
• Molecular mediators of hepatic steatosis and liver injury.

  2004cited by this paper
• Fatty acid profiles in relation to triglyceride level in the liver of dairy cows.

  2004cited by this paper
• Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

  2004cited by this paper
• Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.

  2003cited by this paper
• Triglyceride accumulation protects against fatty acid-induced lipotoxicity

  2003cited by this paper
• Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

  2003cited by this paper
• Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS.

  2003cited by this paper
• Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function.

  2003cited by this paper
• The physiology of cellular liporegulation.

  2003cited by this paper
• Human hepatocytes as a tool for studying toxicity and drug metabolism.

  2003cited by this paper
• Saturated free fatty acids, palmitic acid and stearic acid, induce apoptosis by stimulation of ceramide generation in rat testicular Leydig cell.

  2003cited by this paper
• Non‐alcoholic fatty liver disease: An overview

  2002cited by this paper
• Sensitive markers used to identify compounds that trigger apoptosis in cultured hepatocytes.

  2002cited by this paper
• Palmitate-Induced Apoptosis of Microvascular Endothelial Cells and Pericytes

  2002cited by this paper
• Recent Developments on Human Cell Lines for the Bioartificial Liver

  2002cited by this paper
• Different role of saturated and unsaturated fatty acids in beta-cell apoptosis.

  2002cited by this paper
• Lipoapoptosis: its mechanism and its diseases.

  2002cited by this paper
• Different role of saturated and unsaturated fatty acids in β-cell apoptosis

  2002cited by this paper
• Animal Models of Steatosis

  2001cited by this paper
• Palmitate-induced Apoptosis Can Occur through a Ceramide-independent Pathway*

  2001cited by this paper
• Nile Red Binding to HepG2 Cells: An Improved Assay for In Vitro Studies of Hepatosteatosis

  2001cited by this paper
• Flow cytometry of apoptotic cell death.

  2000cited by this paper
• Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A.

  2000cited by this paper
• Nuclear Sterol Regulatory Element-binding Proteins Activate Genes Responsible for the Entire Program of Unsaturated Fatty Acid Biosynthesis in Transgenic Mouse Liver*

  1998cited by this paper
• Tetracycline-Induced Steatosis in Primary Canine Hepatocyte Cultures

  1997cited by this paper
• Tetracycline-induced steatosis in primary canine hepatocyte cultures.

  1997cited by this paper
• Factors underlying the variability of lipid droplet fluorescence in MA-10 Leydig tumor cells.

  1994cited by this paper
• Cytotoxic effects of food additives and pharmaceuticals on cells in culture as determined with the neutral red assay.

  1990cited by this paper
• Spectrofluorometric studies of the lipid probe, nile red.

  1985cited by this paper

• LncRNA TUG1 promotes hepatic lipid accumulation by targeting the miR-29a-3p/SREBP-2/HMGCR axis in MAFLD

  2026cites this paper
• Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models.

  2026cites this paper
• High-glucosinolate Brassica rapa lines mitigate diet-induced hepatic steatosis through activation of the AMPK/SIRT1 and NRF2 pathways

  2026cites this paper
• Protective effects of Gnetum montanum extract against oleic acid-induced lipotoxicity in hepatocytes

  2026cites this paper
• Modeling fatty liver disease and progression with stem cell derived hepatocytes

  2026cites this paper
• Protective Effects of Neutral Lipids from Phaeodactylum tricornutum on Palmitate-Induced Lipid Accumulation in HepG2 Cells: An In Vitro Model of Non-Alcoholic Fatty Liver Disease

  2026cites this paper
• Nettle Leaf Water Extracts for Hepatoprotection: Insights into Bioactivity and Mitochondrial Function

  2025cites this paper
• 3‐Oxo‐22α‐Hydroxy‐Rotundic Acid Alleviates Hyperlipidemia in Mice by Modulating Lipid Metabolism Through the AMPK‐SREBP‐1c‐PPARα Pathway

  2025influential citation
• Generation and characterization of a chronic in vitro model to study the early stage of metabolic dysfunction-associated steatotic liver disease (MASLD).

  2025cites this paper
• Application of rapid evaporative ionization mass spectrometry in preclinical and clinical analyses of steatotic liver tissues and cells

  2025cites this paper
• Carrier-Free Silibinin/Sorafenib Microparticles Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Fatty Acid Metabolism

  2025cites this paper
• Engineering a three-dimensional liver steatosis model.

  2025cites this paper
• Cell Homeostasis or Cell Death—The Balancing Act Between Autophagy and Apoptosis Caused by Steatosis-Induced Endoplasmic Reticulum (ER) Stress

  2025influential citation
• Targeting CRM1-HMGB1 Nuclear Translocation in Type 2 Diabetes-Driven Metabolic Dysfunction Associated Steatotic Liver Disease

  2025cites this paper
• ACSL1 Contributes to Metabolic-Associated Fatty Liver Disease by Mediating Arachidonic Acid Metabolism.

  2025cites this paper
• Activated Immune and Complement C3 Are Potential Contributors in MASH via Stimulating Neutrophil Extracellular Traps

  2025cites this paper
• Gypenosides Ameliorate Hyperlipidemia by Activating Lipophagy through Modulation of the AMPK/mTOR/ULK1 Signaling Pathway.

  2025cites this paper
• MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting CPT1A and ACSL4

  2025cites this paper
• A Physiological Oxygen Gradient Liver-Zonation-on-a-Chip Reveals HIF-2α Intervention in Hepatic Lipotoxicity.

  2025cites this paper
• Fluorescent probe for simultaneous visualization of lipid peroxidation and lipid droplets accumulation in living cells.

  2025cites this paper
• Effects of l-carnitine, taurine and vitamin E in cellular Non-alcoholic fatty liver disease models

  2025cites this paper
• Human Hepatocytes in Experimental Steatosis: Influence of Donor Sex and Sex Hormones

  2025cites this paper
• FucoVital® inhibits fatty acid accumulation in liver cells in vitro and reduces triglycerides levels in patients with NAFLD

  2025cites this paper
• MicroRNA-18a-5p regulates hepatic lipid accumulation in response to high-fat diet

  2025cites this paper
• Lipid-clearing tea aqueous extract alleviates dyslipidaemia in vivo and in vitro by activating the AMPK pathway

  2025cites this paper
• Unraveling the genetic link: causal effects and PRS predictions of adiposity‐related health conditions in East Asian individuals

  2025cites this paper
• COMPARATIVE ANALYSIS OF METHODS FOR INDUCING STEATOSIS USING A COMPLEX OF FATTY ACID - BOVINE SERUM ALBUMIN IN AN IN VITRO MODEL ON HEPG2 CELLS

  2025cites this paper
• Scutellariae Radix and Coptidis Rhizoma Improve NAFLD via Regulation of SIRT6/ACSL5 Pathway and SCD1.

  2025cites this paper
• miR-125b-5p regulates FFA-induced hepatic steatosis in L02 cells by targeting estrogen-related receptor alpha.

  2025cites this paper
• MiR-199b-5p inhibition improves inflammation and oxidative stress damage in OA-induced non-alcoholic fatty liver disease through targeting SIRT1

  2025cites this paper
• Discovery of Cysteine Carboxyalkylations by Real-Time Isotopic Signature Targeted Profiling.

  2025cites this paper
• Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver disease

  2025cites this paper
• IL‐25 Improves MAFLD by Suppressing the Notch Signalling in Hepatic Macrophages

  2025cites this paper
• LIMA1 O‐GlcNAcylation Promotes Hepatic Lipid Deposition through Inducing β‐catenin‐Regulated FASn Expression in Metabolic Dysfunction‐Associated Steatotic Liver Disease

  2025cites this paper
• Effect of metformin on cell proliferation and apoptosis in steatosis HepG2 cell model

  2025cites this paper
• Hydroxysteroid 17β‐dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high‐fat diet obese mice

  2025cites this paper
• Liver B Cells Promotes MASLD Progression via the Apelin/APLNR System

  2025cites this paper
• Capsaicin and Its Combination with Oleic Acid Affect Membrane Fatty Acid Remodeling and Cytokine–Chemokine Secretion in HepG2 Cells

  2025cites this paper
• PPARα activation attenuates neobavaisoflavone-induced hepatotoxicity by modulating metabolic disorder and oxidative stress.

  2025cites this paper
• Metformin and berberine synergistically improve NAFLD via the AMPK–SREBP1–FASN signaling pathway

  2025cites this paper
• Effects of Lacticaseibacillus rhamnosus LB1.5 as potential probiotic supplement on the liver and adipose tissue of adult male mice to a high-fat diet

  2025cites this paper
• AMPK-Targeting Effects of (−)-Epicatechin Gallate from Hibiscus sabdariffa Linne Leaves on Dual Modulation of Hepatic Lipid Accumulation and Glycogen Synthesis in an In Vitro Oleic Acid Model

  2025cites this paper
• Bisphenol A Alters the Expression of Genes Involved in Lipogenesis, Inflammation, and Oxidative Stress in the Liver of Adult Zebrafish

  2025cites this paper
• Engineering Three-Dimensional Cellular Organization by Regulating Bound Water-Mediated Cell–Substrate Interactions for Disease Modeling

  2025cites this paper
• CircSETD2 impairs hepatic lipid homeostasis in metabolic dysfunction-associated fatty liver disease by binding CPS1.

  2025cites this paper
• Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans

  2025cites this paper
• Reference genes for quantitative real-time polymerase chain reaction in in vitro non-alcoholic fatty liver disease.

  2025cites this paper
• LEADS - a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing.

  2025cites this paper
• Understanding the early onset of intracellular lipid accumulation induced by oleic and palmitic acids in HepG2 cells.

  2025cites this paper
• Impact of Endocrine Disruptors on Key Events of Hepatic Steatosis in HepG2 Cells.

  2025cites this paper
• Metabolic Characteristics of Schisantherin B in Mice with Metabolic-Associated Fatty Liver Disease

  2025cites this paper
• Lipid-lowering mechanism of Swietenia macrophylla King leaves through SREBP-1c/FASN axis and RNA sequencing validation

  2025cites this paper
• Hesperidin alleviates nonalcoholic steatohepatitis by inhibiting cellular senescence through regulation of the BMP4/P21 pathway

  2025cites this paper
• Targeting FXR in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk

  2025cites this paper
• Primary Human Tissue Models for Metabolic Dysfunction‐Associated Liver Disease ‐ toward Streamlining Drug Discovery with Patient‐Derived Assays

  2025cites this paper
• Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches.

  2024cites this paper
• Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease

  2024cites this paper
• Methyl Cinnamate (MC) Alleviates Free Fatty Acids (FFAs) Induced Lipid Accumulation Through the AMPK Pathway in HepG2 Cells

  2024cites this paper
• Curcumin Prevents Free Fatty Acid-Induced Lipid Accumulation via Targeting the miR-22-3p/CRLS1 Pathway in HepG2 Cells

  2024cites this paper
• Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances

  2024cites this paper
• Organoid-guided Precision Hepatology for Metabolic Liver Disease.

  2024cites this paper
• Plant miR8126-3p and miR8126-5p Decrease Lipid Accumulation through Modulation of Metabolic Genes in a Human Hepatocyte Model That Mimics Steatosis

  2024cites this paper
• Oridonin loaded peptide nanovesicles alleviate nonalcoholic fatty liver disease in mice

  2024cites this paper
• Chlorajaponins A—Q, Lindenane‐Related Sesquiterpenoid Dimers from Chloranthus japonicus and Their Biological Activities

  2024cites this paper
• CD36-mediated podocyte lipotoxicity promotes foot process effacement

  2024cites this paper
• A simple, reliable and easily generalizable cell-based assay for screening potential drugs that inhibit lipid accumulation

  2024cites this paper
• Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease

  2024cites this paper
• Multiple Machine Learning Identifies Key Gene PHLDA1 Suppressing NAFLD Progression

  2024cites this paper
• Therapeutic effects of blue mussel-derived peptides (PIISVYWK and FSVVPSPK) on non-alcoholic fatty liver disease by modulating lipid metabolism and inflammation in high-fat diet-induced mice.

  2024cites this paper
• Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model

  2024cites this paper
• The molecular regulated mechanism of METTL3 and FTO in lipid metabolism of Hu sheep.

  2024cites this paper
• Subcellular expression of CYP2E1 in HepG2 cells impacts response to free oleic and palmitic acid

  2024cites this paper
• (E)-5-hydroxy-7-methoxy-3-(2-hydroxybenzyl)-4-chromanone, a Major Homoisoflavonoid, Attenuates Free Fatty Acid-Induced Hepatic Steatosis by Activating AMPK and PPARα Pathways in HepG2 Cells

  2024cites this paper
• Analysis of gene expression changes during lipid droplet formation in HepG2 human liver cancer cells

  2024cites this paper
• Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells

  2024influential citation
• The immune microenvironment of steatotic hepatocellular carcinoma: Current findings and future prospects

  2024cites this paper
• Engineered Lipids for Intracellular Reactive Oxygen Species Scavenging in Steatotic Hepatocytes.

  2024cites this paper
• Liver organoids: updates on generation strategies and biomedical applications

  2024cites this paper
• Metabolite profiling and bioactivity assessment of cyanobacteria from the Azores reveals unique producers of cytotoxic and lipid reducing compounds

  2024cites this paper
• Hepatic Amyloid Beta-42-Metabolizing Proteins in Liver Steatosis and Metabolic Dysfunction-Associated Steatohepatitis

  2024cites this paper
• Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease

  2024cites this paper
• ZBP1-mediated apoptosis and inflammation exacerbate steatotic liver ischemia/reperfusion injury

  2024cites this paper
• Superimposed Electric Field Enhanced Electrospray for High‐Throughput and Consistent Cell Encapsulation

  2024cites this paper
• (+)Alpha-Lipoic Acid Regulates Lipid Metabolism Gene Expression and Lipidic Profile in a Cellular Model of Fatty Acid Overload.

  2024cites this paper
• Lactucin ameliorates FFA-induced steatosis in HepG2 cells by modulating mitochondrial homeostasis through the SIRT1/PGC-1α signaling axis

  2024cites this paper
• A fish intestinal in vitro model for investigation of lipid metabolism and steatosis.

  2024cites this paper
• Phenotypes of MASLD-associated hepatocellular carcinoma.

  2024cites this paper
• Characterization of diseased primary human hepatocytes in an all-human cell-based triculture system

  2024cites this paper
• Silybin A from Silybum marianum reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids

  2024cites this paper
• Chlorogenic Acid and its Isomers Attenuate NAFLD by Mitigating Lipid Accumulation in Oleic Acid‐Induced HepG2 Cells and High‐Fat Diet‐ Fed Zebrafish

  2024cites this paper
• Ferulic acid reduces GLP‐1 degradation to ameliorate diet‐induced obesity‐associated hepatic steatosis

  2024cites this paper
• Redefining the Role of Ornithine Aspartate and Vitamin E in Metabolic-Dysfunction-Associated Steatotic Liver Disease through Its Biochemical Properties

  2024cites this paper
• Enhanced Venous Thrombosis and Hypercoagulability in Murine and Human Metabolic Dysfunction-Associated Steatohepatitis.

  2024cites this paper
• Tuberostemonine alleviates high-fat diet-induced obesity and hepatic steatosis by increasing energy consumption.

  2023cites this paper
• The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels.

  2023cites this paper
• High-fat diet promotes multiple binges-induced liver injury via promoting hepatic macrophage proinflammatory polarization.

  2023cites this paper
• Inferring secretory and metabolic pathway activity from omic data with secCellFie

  2023cites this paper
• Fish SCD1 promotes SGIV infection via modulating the formation of lipid droplets and TBK1/MDA5-activated IFN signal pathway

  2023cites this paper
• Intestines-erythrocytes-mediated bio-disposition deciphers the hypolipidemic effect of berberine from Rhizoma Coptidis: A neglected insight.

  2023cites this paper
• Lipidomic study and diagnosis of hepatocellular carcinoma tumor with rapid evaporative ionization mass spectrometry

  2023cites this paper